Sviss - þýska - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - pantoprazolum - magensaftresistente tabletten - pantoprazolum 20.00 mg ut pantoprazolum natricum sesquihydricum, natrii carbonas, mannitolum, crospovidonum, povidonum k 90, calcii stearas, Überzug: hypromellosum, povidonum k 25, e 171, e 172 (flavum), propylenglycolum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, drucktinte: lacca, e 172 (rubrum), e 172 (nigrum), e 172 (flavum), ammoniae solutio concentrata, pro compresso obducto corresp. natrium 3.38 mg. - protonenpumpenhemmer - synthetika

Sviss - þýska - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - pantoprazolum - magensaftresistente tabletten - pantoprazolum 40.00 mg ut pantoprazolum natricum sesquihydricum, natrii carbonas, mannitolum, crospovidonum, povidonum k 90, calcii stearas, Überzug: hypromellosum, povidonum k 25, e 171, e 172 (flavum), propylenglycolum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, drucktinte: lacca, e 172 (rubrum), e 172 (nigrum), e 172 (flavum), ammoniae solutio concentrata, pro compresso obducto corresp. natrium 6.75 mg. - protonenpumpenhemmer - synthetika

Sviss - þýska - Swissmedic (Swiss Agency for Therapeutic Products)

devatis ag - lenalidomidum - hartkapseln - lenalidomidum 2.5 mg, lactosum 20.0 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.204 mg, magnesii stearas, kapselhülle: gelatina, e 132, titanii dioxidum, e 172 (flavum), drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, e 172 (nigrum), kalii hydroxidum, pro capsula. - onkologikum - synthetika

Sviss - þýska - Swissmedic (Swiss Agency for Therapeutic Products)

devatis ag - lenalidomidum - hartkapseln - lenalidomidum 5.0 mg, lactosum 40.0 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.408 mg, magnesii stearas, kapselhülle: gelatina, titanii dioxidum, drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, e 172 (nigrum), kalii hydroxidum, pro capsula. - onkologikum - synthetika

Sviss - þýska - Swissmedic (Swiss Agency for Therapeutic Products)

devatis ag - lenalidomidum - hartkapseln - lenalidomidum 7.5 mg, lactosum 60.0 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.612 mg, magnesii stearas, kapselhülle: gelatina, titanii dioxidum, e 172 (flavum), drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, e 172 (nigrum), kalii hydroxidum, pro capsula. - onkologikum - synthetika

Sviss - þýska - Swissmedic (Swiss Agency for Therapeutic Products)

devatis ag - lenalidomidum - hartkapseln - lenalidomidum 10.0 mg, lactosum 80.0 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.816 mg, magnesii stearas, kapselhülle: gelatina, e 132, titanii dioxidum, e 172 (flavum), drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, e 172 (nigrum), kalii hydroxidum, pro capsula. - onkologikum - synthetika

Sviss - þýska - Swissmedic (Swiss Agency for Therapeutic Products)

devatis ag - lenalidomidum - hartkapseln - lenalidomidum 15.0 mg, lactosum 120.0 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 1.224 mg, magnesii stearas, kapselhülle: gelatina, e 132, titanii dioxidum, drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, e 172 (nigrum), kalii hydroxidum, pro capsula. - onkologikum - synthetika

Sviss - þýska - Swissmedic (Swiss Agency for Therapeutic Products)

devatis ag - lenalidomidum - hartkapseln - lenalidomidum 20.0 mg, lactosum 160.0 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 1.632 mg, magnesii stearas, kapselhülle: gelatina, e 132, titanii dioxidum, e 172 (flavum), drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, e 172 (nigrum), kalii hydroxidum, pro capsula. - onkologikum - synthetika

Sviss - þýska - Swissmedic (Swiss Agency for Therapeutic Products)

devatis ag - lenalidomidum - hartkapseln - lenalidomidum 25.0 mg, lactosum 200.0 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 2.04 mg, magnesii stearas, kapselhülle: gelatina, titanii dioxidum, drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, e 172 (nigrum), kalii hydroxidum, pro capsula. - onkologikum - synthetika

Sviss - þýska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - candesartanum cilexetilum, amlodipinum - kapseln - candesartanum cilexetilum 16 mg, amlodipinum 5 mg ut amlodipini besilas, lactosum monohydricum 203.9 mg, maydis amylum, carmellosum calcicum, macrogolum 8000, hydroxypropylcellulosum, magnesii stearas, kapselhülle: e 104, e 171, gelatina, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - essentielle hypertonie - synthetika